PHARMA MAR, S.A. «...678910...» Page 10 out of 23 21/12/2022 17:35 PHARMA MAR, S.A. On corporate governance The Company announces the appointment by co-option of a new Director, amendments to the Board of Directors' Regulations and changes in the composition of the Executive Committee. Register number: 19730 12/12/2022 08:26 PHARMA MAR, S.A. On business and financial situation The Company announces a US$10 million milestone payment from Janssen Register number: 19521 27/10/2022 17:37 PHARMA MAR, S.A. Other relevant information - On business and financial situation The Company files third quarter 2022 financial information and announces a conference call with analysts and investors. Register number: 18908 06/10/2022 17:42 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement between 01/07/2022 and 30/09/2022 Register number: 18578 03/10/2022 11:19 PHARMA MAR, S.A. On corporate governance The Company regrets to announce the death of its Director Mr. José Félix Pérez-Orive Carceller Register number: 18505 27/09/2022 17:42 PHARMA MAR, S.A. On business and financial situation The Company announces the cessation of the diagnostic activity carried out through its subsidiary Genomica, S.A.U. Register number: 18434 23/09/2022 10:00 PHARMA MAR, S.A. On business and financial situation The Company announces the approval of Zepzelca® (lurbinectedin) for the treatment of metastatic Small Cell Lung Cancer in South Korea Register number: 18376 05/08/2022 08:02 PHARMA MAR, S.A. On business and financial situation The Company announces the designation of lurbinectedin as Innovative Medicine by the UK’s MHRA. Register number: 17853 04/08/2022 15:15 PHARMA MAR, S.A. General Shareholders’ Meeting Regulations La sociedad remite el Reglamento de la junta general de accionistas Register number: 17851 27/07/2022 17:51 PHARMA MAR, S.A. On business and financial situation The Company publishes the presentation to analysts and investors announced for tomorrow regarding the results for the first half of 2022. Register number: 17623 Page 10 out of 23 «...678910...»
